| Name | Value |
|---|---|
| CODE | 103565 |
| COMPONENT | HIV 1 GROUP O RNA+HIV 1 GROUP M RNA+HIV 2 RNA+HEPATITIS C VIRUS RNA+HEPATITIS B VIRUS DNA+HEPATITIS E VIRUS RNA |
| CHECK DIGIT | 8 |
| PROPERTY | PRESENCE OR THRESHOLD |
| DATE LAST CHANGED | 2024-02-27 00:00:00 |
| CHANGE TYPE | ADD |
| TIME ASPECT | POINT |
| SYSTEM | SER/PLAS/BLD~DONOR |
| SCALE TYPE | Ordinal |
| METHOD TYPE | PROBE AMP TAR |
| CLASS | MICRO |
| FULLY SPECIFIED NAME | HIV 1 GROUP O RNA+HIV 1 GROUP M RNA+HIV 2 RNA+HEPATITIS C VIRUS RNA+HEPATITIS B VIRUS DNA+HEPATITIS E VIRUS RNA:PRTHR:PT:SER/PLAS/BLD~DONOR:ORD:PROBE.AMP.TAR |
| SHORTNAME | HIV1,2+HCV+HEV RNA+HBV DNA S/P/B DR NAPB |
| LONG COMMON NAME | HIV 1 GROUP O RNA+HIV 1 GROUP M RNA+HIV 2 RNA+HEP C RNA+HEP B DNA+HEP E RNA [PRESENCE] IN SERUM, PLASMA OR BLOOD FROM DONOR BY NAA WITH PROBE DETECTION |
| COMMENTS | This term is created for but not restricted in use to the cobas? MPX-E test, wh ich is FDA-approved qualitative in vitro nucleic acid screening test for human i mmunodeficiency virus type 1 (HIV-1) RNA (HIV-1 Group M & Group O RNA), HIV-2 RN A, hepatitis B virus (HBV) RNA, hepatitis C virus (HCV) RNA, hepatitis E virus ( HEV) RNA in specimens from individual donors. This test is intended for determi ning the eligibility of donors and is not intended for clinical or diagnostic ev aluation of patients. |
| MASTER ENTRY FOR VUID | YES |
| VUID | 5373023 |
| EFFECTIVE DATE/TIME |
|